Raltegravir is a drug that belongs to a class of medicines known as HIV integrase inhibitors. HIV integrase is an enzyme necessary for insertion of viral DNA into the host cell genome. This further inhibits viral gene expression and replication.
It is active against HIV-1 and HIV-2.